{
    "2018-04-11": [
        [
            {
                "time": "2018-04",
                "original_text": "[增持评级]2018年4月医药行业发展明确 龙头持续向好",
                "features": {
                    "keywords": [
                        "医药行业",
                        "发展趋势",
                        "龙头",
                        "持续向好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-Q1",
                "original_text": "[增持评级]医药板块2018年一季报业绩前瞻：高景气细分领域延续良好增长",
                "features": {
                    "keywords": [
                        "医药板块",
                        "一季报",
                        "高景气",
                        "细分领域",
                        "良好增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2017-Q4",
                "original_text": "[强于大市评级]医药生物行业专题研究：从样本医院数据看药品结构调整：36个谈判品种2017Q4放量增长 刚需药品龙头增速稳健",
                "features": {
                    "keywords": [
                        "医药生物",
                        "样本医院",
                        "药品结构调整",
                        "谈判品种",
                        "放量增长",
                        "刚需药品",
                        "龙头",
                        "增速稳健"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "把脉二季度投资机会 私募聚焦低估值标的",
                "features": {
                    "keywords": [
                        "二季度",
                        "投资机会",
                        "私募",
                        "低估值标的"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}